Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » NeoGenomics Preliminary Q1 Revenues Increase 11 Percent; Firm Withdraws 2020 Guidance

NeoGenomics Preliminary Q1 Revenues Increase 11 Percent; Firm Withdraws 2020 Guidance

Apr 09, 2020
|
staff reporter

NEW YORK – NeoGenomics reported on Thursday that its preliminary revenues for the first quarter of 2020 are expected to increase 11 percent year over year to $106 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Lots of Voided Tests

Nearly 30,000 COVID-19 tests the UK sent to the US came back as void, according to the Telegraph.

Score Disparities Found

Black principal investigators receive less favorable application scores when seeking US National Institutes of Health grants, the Chronicle of Higher Education reports.

Maybe an RNA-DNA World

New Scientist reports that both RNA and DNA may have been involved in the emergence of life on Earth.

Nature Papers Describe Sequencing of Sperm Genomes, Approach to Detect Residual Cancer, More

In Nature this week: new Sperm-seq method enables crossover analysis, tumor-informed detection approach for minimal residual disease, and more.

What's Popular?

In Business News

  1. Twist Bioscience Prices $100M Stock Offering

  2. 10x Genomics, Collaborators Develop Targeted Single-Cell Gene Expression Methods

    Premium

  3. FDA Issues Emergency Use Authorizations for Gravity Diagnostics, Aspirus, CSI Coronavirus Tests

  4. Guardant Health Prices $315M Public Offering

  5. OraSure Technologies Prices $82.5M Stock Offering

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.